SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Gustafsson Helena)
 

Search: WFRF:(Gustafsson Helena) > Soluble Urokinase P...

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19

Enocsson, Helena (author)
Linköpings universitet,Avdelningen för inflammation och infektion,Medicinska fakulteten
Idoff, Cornelia (author)
Linköpings universitet,Avdelningen för inflammation och infektion,Medicinska fakulteten
Gustafsson, Annette (author)
Region Östergötland, Infektionskliniken i Östergötland
show more...
Govender, Melissa (author)
Linköpings universitet,Avdelningen för molekylär medicin och virologi,Medicinska fakulteten
Hopkins, Francis (author)
Linköpings universitet,Avdelningen för molekylär medicin och virologi,Medicinska fakulteten
Larsson, Marie (author)
Linköpings universitet,Avdelningen för molekylär medicin och virologi,Medicinska fakulteten
Nilsdotter-Augustinsson, Åsa, 1962- (author)
Linköpings universitet,Avdelningen för inflammation och infektion,Medicinska fakulteten,Region Östergötland, Infektionskliniken i Östergötland
Sjöwall, Johanna (author)
Linköpings universitet,Avdelningen för inflammation och infektion,Medicinska fakulteten,Region Östergötland, Infektionskliniken i Östergötland
show less...
 (creator_code:org_t)
2021-12-02
2021
English.
In: Frontiers in Medicine. - : Frontiers Media SA. - 2296-858X. ; 8
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background: Efficient healthcare based on prognostic variables in hospitalised patients with COVID-19 could reduce the risk of complications and death. Recently, soluble urokinase Plasminogen Activator Receptor (suPAR) was shown to predict respiratory failure, kidney injury, and clinical outcome in patients with SARS-CoV-2 infection. The aim of this study was to investigate the value of suPAR as a prognostic tool, in comparison with other variables, regarding disease severity and length of hospital stay in patients with COVID-19.Patients and Methods: Individuals hospitalised with COVID-19 (40 males, 20 females; median age 57.5 years) with a median symptom duration of 10 days and matched, healthy controls (n = 30) were included. Admission levels of suPAR were measured in serum by enzyme-linked immunosorbent assay. Blood cell counts, C-reactive protein (CRP) levels, lactate dehydrogenase (LDH), plasma creatinine and estimated glomerular filtration rates were analysed and oxygen demand, level of care and length of hospitalisation recorded.Results: Patients had significantly higher suPAR levels compared to controls (P < 0.001). Levels were higher in severely/critically (median 6.6 ng/mL) compared with moderately ill patients (median 5.0 ng/mL; P = 0.002). In addition, suPAR levels correlated with length of hospitalisation (rho = 0.35; P = 0.006). Besides suPAR, LDH, CRP, neutrophil count, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratio, body mass index and chronic renal failure were discriminators of COVID-19 severity and/or predictors of length of hospitalisation.Conclusion: Admission levels of suPAR were higher in patients who developed severe/critical COVID-19 and associated with length of hospital stay. In addition, we showed that suPAR functioned as an independent predictor of COVID-19 disease severity.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Keyword

suPAR; COVID-19; biomarker; disease severity; respiratory failure; length of hospital stay

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view